Clinical Trial Update: Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating EUS-guided 22-gauge core biopsy versus fine-needle aspiration for suspected pancreatic neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Tumor

Snippet

Sponsor: University of Virginia | Conditions: Pancreatic Tumor | Phase 4 | Status: COMPLETED